Skip to content
Open access

Exploration of novel indolo[2,3-b]quinoxaline hybrids as InhA inhibitors: A multi-disciplinary approach involving synthesis, antimycobacterial evaluation and computational studies.

Sep 2026 · European journal of medicinal chemistry · Vol 320, pp. 119317 · 1 citation
Medicine

TL;DR

A library of 52 indolo[2,3-b]quinoxaline derivatives was designed and synthesized using a pharmacophore-hybridization strategy and subjected to comprehensive biological and computational evaluation, highlighting indolo[2,3-b]quinoxaline as promising antitubercular scaffold for further development.

Read PDF

Similar papers

Open access Aug 2026

Synthesis of novel 11H-indeno[1,2-b]quinoxaline derivatives and their in vitro and in silico insights into anticancer activities

A novel series of 11H-indeno[1,2-b]quinoxaline derivatives were rationally designed and synthesised, with the aim of exploring their potential anticancer properties, and anticancer efficacy and antitumor efficacy were demonstrated.

F. A. El-Samahy, Ghada A Eldeken, Ehab M. Zayed et al. · 1 citation
Open access Sep 2026

Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole‐Based Hydrazide Derivatives as Potential Anti‐Tuberculosis Agents

Findings highlight the potential of benzisothiazole‐based hydrazide derivatives as promising scaffolds for the development of new antitubercular agents and suggest InhA as a potential molecular target.

V. Sharma, Arun Sharma, Ruchi Poria et al. · 0 citations
Open access Sep 2026

Synthesis, molecular docking and biological activity assessment of novel 1,3,4-oxadiazole derivatives as broad-spectrum antifungal candidates

The presence of fungistatic properties and potential resistance issues associated with current azole drugs have created a growing demand for discovering novel antifungal agents without these negative attributes. This study introduces the synthesis of a unique series of 4-(5-(benzylthio)-1,3,4-oxadiazol-2-yl) phenol der...

Mohammad Shafiei, Sara Masoudinia, Mahfam Moradi et al. · 0 citations
Open access Aug 2026

In silico Design of N-Substituted Quinoline-Isatin Hybrids for Multiple Targeted enzymes for Anti-Microbial Activity

The World Health Organization reports that approximately 700,000 people are affected by Antimicrobial Resistance (AMR) each year. This growing concern has accelerated the search for new antibacterial agents. Fluoroquinolones are key broad-spectrum antibiotics and recent interest in Isatin derivatives has revealed promi...

Vignesh Sekar, Revathi Gnanavelou, Sowmiya Perinbaraj et al. · 0 citations
Open access Sep 2026

Design and in silico screening of novel isoniazid-based Schiff base derivatives followed by synthesis and biological evaluation of the lead compound against Mycobacterium tuberculosis H37Rv

The findings suggest that isoniazid-based Schiff base derivatives represent a promising scaffold for the development of new antitubercular agents, with SLB-5 emerging as a promising candidate for further investigation.

Shivani L. Bhuse, P. M. Patil, Rajat R. Durbule · 0 citations
Open access Aug 2026

Development of isonicotinoyl-azole hybrids as potential InhA inhibitors for anti-tubercular activity.

The development of innovative treatment medicines that can overcome drug resistance and intracellular persistence is necessary since tuberculosis (TB) continues to be a significant worldwide health burden. In this work, series of hybrid compounds containing azole moieties, imine/semicarbazide linkers, and isonicotinoyl...

Wagdy M. Eldehna, Zainab M. Elsayed, M. Korycka-Machała et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.